DUS1L and central nervous system cancer: To investigate this possibility in glioma patients, it is necessary to first investigate if glioma tissues with higher DUS1L expression contain more tRNATyr(GUA) precursor, tRNAPhe, and tRNAAla(AGC) and less mature tRNATyr(GUA).